Sporotrichosis classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 14: | Line 14: | ||
'''Fixed form:''' | '''Fixed form:''' | ||
*Staying localized within the [[subcutaneous]] tissue, the [[fungus]] transforms into its [[yeast]] form. | *Staying localized within the [[subcutaneous]] tissue, the [[fungus]] transforms into its [[yeast]] form. | ||
*Manifests at the site of [[inoculation]] with at least one, frequently [[Ulcerated lesion|ulcerated, lesion]] | *Manifests at the site of [[inoculation]] with at least one, frequently [[Ulcerated lesion|ulcerated, lesion]] | ||
*The [[lesions]] are characterized by red edges due to [[capillary]] dilation and congestion. | |||
*Fixed form sporotrichosis may spontaneously regress <ref name="article3">Saha A, De A, Datta P, Das N. Fixed cutaneous sporotrichosis: a diagnostic challenge overcome by incidental discovery of asteroid bodies S. Journal of Pakistan Association of Dermatologists. 2010;(20):120-122.></ref> | *Fixed form sporotrichosis may spontaneously regress <ref name="article3">Saha A, De A, Datta P, Das N. Fixed cutaneous sporotrichosis: a diagnostic challenge overcome by incidental discovery of asteroid bodies S. Journal of Pakistan Association of Dermatologists. 2010;(20):120-122.></ref> | ||
*Fixed form sporotrichosis is the main clinical presentation in child patients. | *Fixed form sporotrichosis is the main clinical presentation in child patients. | ||
| Line 29: | Line 30: | ||
'''Disseminated cutaneous form:''' | '''Disseminated cutaneous form:''' | ||
*Manifests upon the hematogenous dissemination of the yeast form of ''S. schenckii'' | *Manifests upon the hematogenous dissemination of the yeast form of ''S. schenckii'' | ||
*Not associated with extracutaneous involvement | *Not associated with extracutaneous involvement | ||
*Characterized by greater than or equal to three epidermal [[lesions]], which form on at least two noncontiguous sites on the body | *Characterized by greater than or equal to three epidermal [[lesions]], which form on at least two noncontiguous sites on the body | ||
'''Mucosal Form''': | '''Mucosal Form''': | ||
*Typically | *Typically manifests with enlargement of the submandibular and [[Preauricular deep parotid lymph nodes|preauricular]] (anterior to ear tragus) lymph nodes | ||
*Nasal mucosa is a variant of mucosal form sporotrichosis, which frequently involves septum [[lesions]] characterized by bloody discharge and crustal detachment.<ref name="pmid25614735" /> | *Nasal mucosa is a variant of mucosal form sporotrichosis, which frequently involves septum [[lesions]] characterized by bloody discharge and crustal detachment.<ref name="pmid25614735" /> | ||
| Line 43: | Line 44: | ||
*Most common extracutaneous form of sporotrichosis | *Most common extracutaneous form of sporotrichosis | ||
*Cutaneous [[lesion|lesions]] rarely manifest in cases of osteoarticular sporotrichosis. | *Cutaneous [[lesion|lesions]] rarely manifest in cases of osteoarticular sporotrichosis. | ||
*Usually starts as monoarticular disease without systemic illness | *Usually starts as monoarticular disease without systemic illness | ||
*May manifest by contiguity or hematogenous spread<ref name="pmid25614735" /> | *May manifest by contiguity or hematogenous spread<ref name="pmid25614735" /> | ||
*Characterized by the involvement of bones and joints | *Characterized by the involvement of bones and joints | ||
*Usually affects joints in the knee, wrist, elbow, and ankle | *Usually affects joints in the knee, wrist, elbow, and ankle | ||
*May manifest with tenosynovitis or [[bursitis]]<ref name="pmid17968818">{{cite journal| author=Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America| title=Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. | journal=Clin Infect Dis | year= 2007 | volume= 45 | issue= 10 | pages= 1255-65 | pmid=17968818 | doi=10.1086/522765 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17968818 }} </ref> | *May manifest with tenosynovitis or [[bursitis]]<ref name="pmid17968818">{{cite journal| author=Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America| title=Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. | journal=Clin Infect Dis | year= 2007 | volume= 45 | issue= 10 | pages= 1255-65 | pmid=17968818 | doi=10.1086/522765 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17968818 }} </ref> | ||
*Frequently associated with [[arthritis]] | *Frequently associated with [[arthritis]] | ||
**In these cases of coexisting diagnoses, [[lesions]] typically manifest along bones adjacent to affected joints. <ref name="ellias">Ellis D. Mycology Online | Sporotrichosis. Mycologyadelaideeduau. 2016. Available at: http://www.mycology.adelaide.edu.au/Mycoses/Subcutaneous/Sporotrichosis/. Accessed January 8, 2016.></ref> | |||
====Primary pulmonary form:==== | ====Primary pulmonary form:==== | ||
*Patients present with primary pulmonary sporotrichosis following the inhalation of ''S. schenckii''. | *Patients present with primary pulmonary sporotrichosis following the inhalation of ''S. schenckii''. | ||
*Typically associated with [[alcoholism]], [[chronic obstructive pulmonary disease]], chronic [[corticosteroid]] use, and [[immunosuppressive]] diseases<ref name="pmid25614735">{{cite journal| author=Mahajan VK| title=Sporotrichosis: an overview and therapeutic options. | journal=Dermatol Res Pract | year= 2014 | volume= 2014 | issue= | pages= 272376 | pmid=25614735 | doi=10.1155/2014/272376 | pmc=PMC4295339 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25614735 }} </ref> | *Typically associated with [[alcoholism]], [[chronic obstructive pulmonary disease]], chronic [[corticosteroid]] use, and [[immunosuppressive]] diseases<ref name="pmid25614735">{{cite journal| author=Mahajan VK| title=Sporotrichosis: an overview and therapeutic options. | journal=Dermatol Res Pract | year= 2014 | volume= 2014 | issue= | pages= 272376 | pmid=25614735 | doi=10.1155/2014/272376 | pmc=PMC4295339 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25614735 }} </ref> | ||
*High risk of delayed diagnosis as a result of the rarity of pulmonary involvement in sporotrichosis manifestation and nonspecific symptoms | *High risk of delayed diagnosis as a result of the rarity of pulmonary involvement in sporotrichosis manifestation and nonspecific symptoms | ||
====Disseminated form:==== | ====Disseminated form:==== | ||
*Characterized by the involvement of at least two sites in the body | *Characterized by the involvement of at least two sites in the body | ||
*Manifests as a result of hematogenic dissemination of ''S. schenckii,'' resulting in multifocal or widespread infection | *Manifests as a result of hematogenic dissemination of ''S. schenckii,'' resulting in multifocal or widespread infection | ||
*May initially manifest as another form of extracutaneous sporotrichosis | *May initially manifest as another form of extracutaneous sporotrichosis | ||
*Strongly associated with [[immunodeficiency]] | *Strongly associated with [[immunodeficiency]] | ||
Other rare forms of sporotrichosis: | Other rare forms of sporotrichosis: | ||
Revision as of 16:50, 28 January 2016
|
Sporotrichosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sporotrichosis classification On the Web |
|
American Roentgen Ray Society Images of Sporotrichosis classification |
|
Risk calculators and risk factors for Sporotrichosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alison Leibowitz [2]
Overview
Sporotrichosis may be classified, according to the location of the lesions, into particular subtypes: fixed cutaneous, lymphocutaneous, disseminated cutaneous, and extracutaneous/systemic. These subtypes may be further separated into increasingly specific forms based upon clinical manifestations.
Classification
- Presentations vary based upon numerous factors, such as the patient’s immunological status, the severity and depth of the inoculum, and the particular strain’s thermal zone of tolerance and pathogenicity.
Cutaneous Forms
Cutaneous forms of Sporotrichosis typically manifest following minor epidermal trauma. Patients may present with multiple forms of cutaneous lesions.
Fixed form:
- Staying localized within the subcutaneous tissue, the fungus transforms into its yeast form.
- Manifests at the site of inoculation with at least one, frequently ulcerated, lesion
- The lesions are characterized by red edges due to capillary dilation and congestion.
- Fixed form sporotrichosis may spontaneously regress [1]
- Fixed form sporotrichosis is the main clinical presentation in child patients.
- Initially manifests as painless nodules, which then become palpable, purulent, and ulcerated
Lymphocutaneous form:
- The yeast form of S. schenckii extends through the nearby lymphatic vessels.[2]
- Approximately 70% of the cases of sporotrichosis may be classified as lymphocutaneous sporotrichosis.[3]
- The primary lesion frequently manifests on the upper extremities and is initially painless.
- Initially a patient will present with a papule or pustule, which later expands into a subcutaneous nodule.[3]
- Subepidermal pressure results in ischemia, and the lesion evolves into a palpable, purulent, and ulcerated nodule.
- Secondary lesions manifest along the adjacent lymphatic pathway.[4]
- The presence of systemic symptoms is rare.
Disseminated cutaneous form:
- Manifests upon the hematogenous dissemination of the yeast form of S. schenckii
- Not associated with extracutaneous involvement
- Characterized by greater than or equal to three epidermal lesions, which form on at least two noncontiguous sites on the body
Mucosal Form:
- Typically manifests with enlargement of the submandibular and preauricular (anterior to ear tragus) lymph nodes
- Nasal mucosa is a variant of mucosal form sporotrichosis, which frequently involves septum lesions characterized by bloody discharge and crustal detachment.[4]
Extracutaneous/Systemic Sporotrichosis
The extracutaneous forms of sporotrichosis are more likely to manifest following the onset of AIDS. These forms are uncommon and difficult to diagnose, but are almost always associated with immunological impairment[4]
Osteoarticular form:
- Most common extracutaneous form of sporotrichosis
- Cutaneous lesions rarely manifest in cases of osteoarticular sporotrichosis.
- Usually starts as monoarticular disease without systemic illness
- May manifest by contiguity or hematogenous spread[4]
- Characterized by the involvement of bones and joints
- Usually affects joints in the knee, wrist, elbow, and ankle
- May manifest with tenosynovitis or bursitis[5]
- Frequently associated with arthritis
Primary pulmonary form:
- Patients present with primary pulmonary sporotrichosis following the inhalation of S. schenckii.
- Typically associated with alcoholism, chronic obstructive pulmonary disease, chronic corticosteroid use, and immunosuppressive diseases[4]
- High risk of delayed diagnosis as a result of the rarity of pulmonary involvement in sporotrichosis manifestation and nonspecific symptoms
Disseminated form:
- Characterized by the involvement of at least two sites in the body
- Manifests as a result of hematogenic dissemination of S. schenckii, resulting in multifocal or widespread infection
- May initially manifest as another form of extracutaneous sporotrichosis
- Strongly associated with immunodeficiency
Other rare forms of sporotrichosis:
- endophthalmitis
- chorioretinitis
References
- ↑ Saha A, De A, Datta P, Das N. Fixed cutaneous sporotrichosis: a diagnostic challenge overcome by incidental discovery of asteroid bodies S. Journal of Pakistan Association of Dermatologists. 2010;(20):120-122.>
- ↑ Stalkup J. R., Bell K., Rosen T.. 2002. Disseminated cutaneous sporotrichosis treated with itraconazole. Cutis 69:371–374.>
- ↑ 3.0 3.1 Goncalves AP. Sporotrichosis. In: Canizares O, Harman R, editors. Clinical Tropical Dermatology, 2nd edn. Philadelphia: Blackwell Scientific Publications; 1992. p. 88-93.>
- ↑ 4.0 4.1 4.2 4.3 4.4 Mahajan VK (2014). "Sporotrichosis: an overview and therapeutic options". Dermatol Res Pract. 2014: 272376. doi:10.1155/2014/272376. PMC 4295339. PMID 25614735.
- ↑ Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America (2007). "Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America". Clin Infect Dis. 45 (10): 1255–65. doi:10.1086/522765. PMID 17968818.
- ↑ Ellis D. Mycology Online | Sporotrichosis. Mycologyadelaideeduau. 2016. Available at: http://www.mycology.adelaide.edu.au/Mycoses/Subcutaneous/Sporotrichosis/. Accessed January 8, 2016.>